QUEBEC CITY, Canada, April 24 /PRNewswire-FirstCall/ - Atrium Biotechnologies Inc. will hold its first Annual General Meeting on Tuesday, May 2, 2006 at 10:30 a.m. at the Ritz-Carlton Hotel, 1228, Sherbrooke West in Montreal, as well as its quarterly conference call and webcast at 2 p.m. The call will follow the press release of Atrium's 2006 first quarter financial results issued earlier that same day. Participants may access the live webcast via the Company's website at www.atrium-bio.com in the "Investors" section, or by telephone using the following numbers: 416-644- 3427, 514-807-8791 or 1-866-250-4910.
A replay of the webcast will also be available on our website at www.atrium-bio.com for a period of 30 days.
About Atrium Biotechnologies
Atrium Biotechnologies Inc. is a leading developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries. Atrium focuses primarily on growing segments of the health and personal care markets which are benefiting from the trends towards healthy living and the ageing of the population. Atrium markets a broad portfolio of active ingredients, specialty chemicals and health and nutrition finished products through its highly specialized sales and marketing network in more than 40 countries, primarily in North America, Europe and Asia.
Additional information about Atrium is available on its Web site at www.atrium-bio.com.
ATRIUM BIOTECHNOLOGIES INC.CONTACT: Media Relations: Frederic Tremblay, HKDP, (514) 395-0375, ext.234, ftremblay@hkdp.qc.ca; Investor Relations: John Dempsey, VicePresident, Finance and Chief Financial Officer, (418) 652-1116, ext. 287,jdempsey@atrium-bio.com
